Loading the lesson
Loading the lesson
Search AllRounder.ai
Search the courses, subjects, tracks, games and features, or jump straight to a page.
Search the courses, subjects, tracks, games and features, or jump straight to a page.
Learn it your way
A short class with Sarah and her students. The other ways are under More.
Sign up free to listen. Transcripts are free to read.
Today, we are going to learn about somatic gene therapy. This therapy introduces genetic alterations in non-reproductive cells, which means changes made won't be inherited by future generations. Can anyone tell me why this is significant?
It's less controversial because it doesn't impact future offspring!
Exactly! Somatic gene therapy is widely accepted in the medical community for this reason. Remember, it’s all about care without heritability. Now, can someone give me an example of where this is applied?
Retinal diseases like Leber’s Congenital Amaurosis?
Great example! Luxturna is a specific treatment for that condition. Let’s recap: Somatic gene therapy alters genes in individual patients and prevents passed-on changes. Any questions?
Now let's delve into gene delivery methods. There are both viral and non-viral methods. Can someone explain what these might include?
Viral methods use modified viruses like AAV, right?
Correct! Viral vectors can ensure long-term gene expression. Non-viral methods, like nanoparticles, tend to evoke a lower immune response. How do you think that benefits patients?
It makes the treatment safer and possibly more effective!
Exactly! So, a good takeaway is that delivery methods are crucial for the success of somatic gene therapy. Any further questions on gene delivery?
In this session, we’ll examine a few case studies. Who can tell me about one successful gene therapy?
Zolgensma for Spinal Muscular Atrophy! It delivers a gene that helps produce a missing protein.
Right! Zolgensma has transformed lives. Reflecting on these cases, what ethical considerations do you think are important in somatic gene therapy?
Informed consent and monitoring patients after treatment to ensure safety.
Spot on! These are critical. In conclusion, case studies like Zolgensma showcase how impactful somatic gene therapy can be when managed correctly.
A medical technique used to treat or prevent diseases by introducing or altering genetic material.
Somatic gene therapy affects only the treated individual, while germline therapy also alters genes in reproductive cells.
Methods such as viral vectors and non-viral techniques critical for the success of gene therapies.
Important topics such as informed consent and long-term monitoring of patients.
For diseases in cells, gene therapy tells, / Changes that stick, no offspring’s mix.
Imagine a world where a child with SMA receives a magical potion that fixes their genes—this potion is Zolgensma, a somatic gene therapy that targets the roots of their struggles directly.
GEL: Gene therapy, Excludes offspring, Long-term effects monitored.
VIRA: Viral vectors Import, Restore, and Alter genes for therapy.
Term
What does somatic gene therapy target?
Click to flip
Term
What is Zolgensma used for?
Click to flip
Term
How do viral vectors function in gene therapy?
Click to flip
A technique that alters genes in non-reproductive cells to treat diseases, which are not inheritable.
A genetic alteration that occurs in reproductive cells and can be passed on to future generations.
Modified viruses used to deliver genetic material into cells effectively.
Techniques that deliver genes without using viruses, such as liposomes or nanoparticles.
Process of ensuring patients understand the risks and benefits before undergoing treatment.
Somatic gene therapy is a medical technique that modifies the genes in body cells to treat diseases, focusing on individual patient care without heritability.
Somatic gene therapy aims to treat genetic disorders by altering the genes in somatic (non-reproductive) cells. Unlike germline gene therapy, which can be passed to future generations, somatic gene therapy only impacts the individual treated. This section elaborates on the principles, application methods, and the ethical considerations surrounding this innovative therapeutic strategy.
Somatic gene therapy targets the genes in non-reproductive cells, aiming to correct genetic disorders for individual patients. Unlike germline gene therapy, somatic changes cannot be inherited, making it more widely accepted and used in clinical settings. The principal advantage lies in its therapeutic potential to treat conditions such as hereditary diseases, cancers, and degenerative disorders.
The chapter covers the delivery systems necessary for somatic gene therapy, including viral and non-viral methods, as well as ex vivo and in vivo approaches. It considers case studies that exemplify its successful implementation, such as therapies for retinal diseases and muscular dystrophy. Moreover, this therapy's ethical implications, regulatory requirements, and safety monitoring post-treatment are discussed, emphasizing the importance of informed consent and long-term surveillance of patients. Overall, somatic gene therapy represents a significant leap forward in personalized medicine, adhering to ethical standards while addressing critical health challenges.